INTERGRATED DIA.H DL 025
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more
Market Cap & Net Worth: INTERGRATED DIA.H DL 025 (8I8)
INTERGRATED DIA.H DL 025 (F:8I8) has a market capitalization of $282.84 Million (€275.55 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #17763 globally and #1858 in its home market, demonstrating a 0.42% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INTERGRATED DIA.H DL 025's stock price €0.47 by its total outstanding shares 581326272 (581.33 Million).
INTERGRATED DIA.H DL 025 Market Cap History: 2021 to 2026
INTERGRATED DIA.H DL 025's market capitalization history from 2021 to 2026. Data shows change from $569.39 Million to $282.84 Million (-6.53% CAGR).
INTERGRATED DIA.H DL 025 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INTERGRATED DIA.H DL 025's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 8I8 by Market Capitalization
Companies near INTERGRATED DIA.H DL 025 in the global market cap rankings as of March 19, 2026.
Key companies related to INTERGRATED DIA.H DL 025 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
INTERGRATED DIA.H DL 025 Historical Marketcap From 2021 to 2026
Between 2021 and today, INTERGRATED DIA.H DL 025's market cap moved from $569.39 Million to $ 282.84 Million, with a yearly change of -6.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €282.84 Million | -16.11% |
| 2025 | €337.14 Million | +49.47% |
| 2024 | €225.56 Million | +32.17% |
| 2023 | €170.66 Million | -49.82% |
| 2022 | €340.13 Million | -40.26% |
| 2021 | €569.39 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of INTERGRATED DIA.H DL 025 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $282.84 Million USD |
| MoneyControl | $282.84 Million USD |
| MarketWatch | $282.84 Million USD |
| marketcap.company | $282.84 Million USD |
| Reuters | $282.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.